baber/WOPTO huggingface dataset:
Patent CA-3082823-A1 (CA)
Inventor: VANDENWORM NICOLAAS JOHANNES
IPC: B63B35/44
Filed: 2018-11-19
Abstract: A method for operating floating vessel wherein the floating vessel comprises a hull having: a bottom surface, a top deck surface, at least two connected sections engaging between the bottom surface and the top deck surface, and at least one fin extending from the hull with an upper fin surface sloping towards the bottom surface and secured to and extending from the hull, the at least one fin configured to provide hydrodynamic performance. The at least two connected sections extend downwardly from the top deck surface toward the bottom surface. The at least two connected sections contain at least two of: an upper portion in section view with a sloping side extending from the top deck section, a cylindrical neck section in profile view, and a lower conical section in profile view with a sloping side extending from the cylindrical neck section
Patent CA-3083210-A1 (CA)
Inventor: EWERT STEFAN
IPC: A61P39/02
Filed: 2018-11-20
Abstract: The present disclosure relates to reversal agents, which specifically bind to anti-Factor XI and/or anti-Factor XIa antibodies, and reverse one or more anticoagulant effects of the anti- Factor XI and/or anti-Factor XIa antibodies, as well as to methods of use thereof, such as methods for reversing anticoagulant effects of such anti-Factor XI and/or anti-Factor XIa antibodies, and to related methods for managing bleeding or bleeding risks.
Patent CA-3083611-A1 (CA)
Inventor: VITTI ROBERT L
IPC: A61K38/17
Filed: 2018-11-29
Abstract: The present invention provides methods for treating or preventing diabetic retinopathy, e.g., nonproliferative diabetic retinopathy, by sequentially administering multiple doses of a VEGF antagonist to a patient. The methods of the present invention include the administration of a 2mg aflibercept by intravitreal injection q8 weeks after three or five initial monthly doses (2q8) or 2 mg q16 weeks after three initial monthly doses and one 8-week interval (2q16). Moreover, the present invention provides methods for reversing or halting the progression NPDR to PDR (e.g., such that the DRSS is reduced by 2 or 3 levels) or preventing the occurrence or reoccurrence of a vision threatening complication by administering aflibercept according to the dosing regimens set forth herein.
Patent CA-3083799-A1 (CA)
Title: Optimisation de reseaux de transport par l'intermediaire d'interfaces utilisateur dynamiques
Inventor: BOWDEN HARRISON JOEL
IPC: G06F3/0481
Filed: 2018-12-21
Abstract: La présente invention pourvoit à une interface utilisateur graphique dynamique permettant de présenter efficacement à des utilisateurs des informations de trajet pertinentes tout au long de l'exécution d'une demande de trajet. Dans certains modes de réalisation, le système détecte un événement déclencheur pendant un trajet, et, sur la base de la détection de l'événement déclencheur, développe ou ferme une partie d'informations dans une interface utilisateur graphique. À l'état fermé, par exemple, la partie d'informations des interfaces utilisateur graphiques comprend un premier ensemble de contenus. Lors de la détection d'un événement déclencheur, le système développe dynamiquement la partie d'informations pour fournir un second ensemble de contenus qui inclut des informations associées au déclencheur détecté.
Patent CA-3084120-A1 (CA)
Inventor: GUILLARD HERVE
IPC: A61K9/50
Filed: 2018-12-18
Abstract: Packaged formulations of gamma-hydroxybutyrate having improved dissolution and chemical stability, packaging for supporting said stability, and therapeutic uses thereof.
Patent CA-3086093-A1 (CA)
Title: Process for the purification of whey protein isolate and formulation thereof
Inventor: FUOCO DOMENICO
IPC: A23J1/20
Filed: 2020-07-07
Abstract: The present document describes a process for the preparation of an amino acid supplement formulation and a formulation thereof. The process comprises filtering a clarified whey protein solution with a filter having a molecular weight cut off between about 50 and 300 kDa to obtain a protein solution; dehydrating the protein solution to obtain a powder; and mixing the powder with lecithin. The present document also describes a process for the purification of a whey protein isolate, comprising filtering a clarified whey protein solution with a filter having a molecular weight cut off between about 50 and 300 kDa to obtain a protein solution; and filtering the protein solution with a filter having a molecular weight cut off between about 1 and 100 kDa to obtain a protein solution having at least one of active albumin, beta-lactoglobulin, and alpha-lactalbumin proteins.
Patent CA-3089345-A1 (CA)
Title: Imagerie et analyse de plaie
Inventor: DACOSTA RALPH
IPC: A61B6/00
Filed: 2019-01-15
Abstract: Selon l'invention, grâce à un dispositif et des systèmes d'imagerie spécifiques, des caractéristiques de plaie d'une plaie deviennent fluorescentes avec une signature spectrale unique lorsqu'elles sont soumises à une lumière d'excitation avec une longueur d'onde ou une plage de longueurs d'onde connues. Des images capturées de celles-ci sont soumises à des analyses de leurs pixels, une pluralité d'images d'entraînement ayant des tailles de plaie connues et des caractéristiques marquées sur celles-ci étant utilisées pour produire des données d'entraînement, qui sont ensuite utilisées pour identifier des caractéristiques de plaie d'images de test en temps réel. Des tailles de plaie, des limites, une présence bactérienne et d'autres caractéristiques peuvent être quantifiées et représentées graphiquement sous la forme d'une superposition sur l'image de plaie d'origine conjointement avec de la documentation associée à la plaie.
Patent CA-3092742-A1 (CA)
Inventor: KAMEN ROBERT
IPC: G21F5/14
Filed: 2019-03-06
Abstract: A compression member for insertion into a pig for transporting a container of biohazardous materials includes a flange maintained in spaced relation with an annulus by pillars; and spaced apart pivotable grip components supported by the annulus and extending downwards from the annulus between respective ones of the pillars towards, but not into contact with, the flange, the pivotable grip components resiliently compressible inwardly against the container when the container is received within the compression member. In use, the compression member receives at least a closure portion of the container and, in turn, is itself received within a complementary annulus of the pig. When being received within the complementary annulus of the pig, the pivotable grip components are urged inwards towards the container thereby to grip the container and provide a spacer for between this portion of the container and the pig.
Patent CA-3093736-A1 (CA)
Title: Limb rehabilitation device
Inventor: TURNER PETER ANTHONY
IPC: A61H15/00
Filed: 2015-11-03
Abstract: A limb rehabilitation device has a supporting structure having a first frame and a second frame pivotably coupled to the first frame, a first roller coupled to the first frame, a second roller coupled to the second frame, and at least one elastic member coupled to the first and the second frames for elastically biasing the second roller towards the first roller such that the first and second rollers are elastically separable from each other for receiving a limb extending therebetween. The first roller has two first therapeutic components along a fffst axis thereof. The second roller has a second therapeutic component along a second axis thereof parallel to the first axis. The two first therapeutic components and the second component have a same size and are positioned such that the second therapeutic component is substantially in between the two first therapeutic components.
Patent CA-3095216-A1 (CA)
Title: Vaccins a base de nanostructures auto-assemblables
Inventor: KING NEIL
IPC: B82Y40/00
Filed: 2019-02-28
Abstract: La présente invention concerne des nanostructures et des vaccins à base de nanostructures. Certaines nanostructures de la présente invention présentent des antigènes capables de déclencher des réponses immunitaires contre des agents infectieux tels que des bactéries, des virus et des pathogènes. Certains vaccins de la présente invention sont utiles pour prévenir ou diminuer la gravité d'une infection par un agent infectieux, comprenant, par exemple et sans limitation, la maladie de Lyme, la coqueluche, l'herpèsvirus, un orthomyxovirus, un paramyxovirus, un pneumovirus, un filovirus, un flavivirus, un réovirus, un rétrovirus, le méningocoque ou le paludisme. Les antigènes peuvent être fixés au cur de la nanostructure par une liaison covalente ou non covalente, notamment sous forme de protéine de fusion ou par d'autres moyens décrits dans l'invention. Des antigènes multimères peuvent éventuellement être affichés le long d'un axe de symétrie de la nanostructure. L'invention concerne également des protéines et des molécules d'acide nucléique codant ces protéines, des compositions de vaccin et des procédés d'administration.
Patent CA-3095452-A1 (CA)
Title: Appareil de generation d'aerosol a partir d'un milieu aerosolisable, article de milieu aerosolisable et procede de determination de parametre d'article
Inventor: MOLONEY PATRICK
IPC: A24F40/20
Filed: 2019-03-27
Abstract: L'invention concerne un appareil destiné à générer un aérosol à partir d'un milieu aérosolisable. L'appareil selon l'invention comprend : un logement ; une chambre destinée à recevoir un article comprenant un milieu aérosolisable et contenant un marqueur ; et un dispositif de commande. Le dispositif de commande est configuré pour recevoir : une première entrée indiquant la vitesse de mouvement de l'article reçu en utilisation dans la chambre ; et une deuxième entrée indiquant un paramètre dudit article. Au moins la deuxième entrée est déterminée en fonction du marqueur.
Patent CA-3097483-A1 (CA)
Title: Designing a virtual preparation and a virtual gingival
Inventor: FISKER RUNE
IPC: A61C13/00
Filed: 2011-10-31
Abstract: Method for generating a 3D virtual model of a dental component for a region of a patient's set of teeth, where the dental component comprises a temporary bridge restoration or a diagnostic wax-up bridge, such that the dental component comprises crowns and at least one pontic. A  digital 3D representation of the set of teeth is obtained, where the digital 3D representation is based on a 3D scan of a pre-prepared configuration of the set of teeth. Using at least one 3D sectioning spline, the part of the digital 3D representation corresponding to the teeth in said region is virtually sectioned. At least part of the inter-proximal surfaces of the virtually sectioned teeth is determined. A jaw-facing surface for the dental component is determined, where the jaw-facing surface is configured for facing a surface which is not available in the digital 3D representation of the pre-prepared set of teeth.
Patent CA-3102232-A1 (CA)
Title: Link quality monitoring method and terminal
Inventor: WU KAI
IPC: H04W24/08
Filed: 2019-06-11
Abstract: Provided in the present disclosure are a link quality monitoring method and terminal, the method comprising: detecting a pre-configured RLM-RS, and determining whether the RLM-RS is received; and according to whether the RLM-RS is received, reporting in-sync or out-of-sync used to indicate link quality.
Patent CA-3104850-A1 (CA)
Title: Thermal performance optimization in a thermal therapy device
Inventor: HUFF BRYAN D
IPC: A61F7/00
Filed: 2019-06-27
Abstract: A rapid contrast therapy system can provide cold, heat/hot/warm (hereafter referred to as "hot"), and/or rapid contrast therapy, which involves rapidly alternating between cold therapy and hot therapy. The system can circulate cold or hot fluid, such as water, through a hose, into a therapy wrap, and then back to the fluid reservoirs of the system. The system can utilize a vapor compression system or other chiller technology to cool the cold water reservoir, and immersion heaters can be used to heat the hot water reservoir.
Patent CA-3105541-A1 (CA)
Title: Cross-linked pyrrolobenzodiazepine dimer (pbd) derivative and its conjugates
Inventor: ZHAO ROBERT YONGXIN
IPC: A61P35/00
Filed: 2018-07-05
Abstract: A novel cross-linked cytotoxic agents, pyrrolobenzo-diazepine dimer (PBD) derivatives, and their conjugates to a cell-binding molecule, a method for preparation of the conjugates and the therapeutic use of the conjugates.
Patent CA-3106517-A1 (CA)
Title: Compositions, utilisations et procedes pour le traitement et/ou la prevention d'un taux eleve de cholesterol, d'hypercholesterolemie et de maladie cardiovasculaire
Inventor: ARORA RAVI
IPC: A61K31/716
Filed: 2019-07-17
Abstract: L'invention concerne une composition pour prévenir et/ou traiter des taux de cholestérol cliniquement élevés, l'hypercholestérolémie et/ou une maladie cardiovasculaire contenant du ß-glucane, de l'huile d'olive ou des polyphénols de feuilles d'olivier ou de l'huile d'olive extra-vierge (HOEV) ou de l'extrait de feuilles d'olivier (EFO), et des substances de levure de riz rouge (par exemple, de l'extrait de levure de riz rouge (ELRR)). L'invention concerne également des procédés d'utilisation de la composition pour traiter et/ou prévenir des taux de cholestérol cliniquement élevés, l'hypercholestérolémie et/ou une maladie cardiovasculaire.
Patent CA-3107880-A1 (CA)
Title: Device and method for deactivating pathogens in blood plasma, blood product and biological product
Inventor: DOLGOPOLOV DMITRY
IPC: A23L3/015
Filed: 2018-08-24
Abstract: Disclosed are methods and devices for reducing the number of pathogens in a liquid. The methods or devices uses one or more of pressure, pressure drop, increased temperature, rate of temperature increase, and inert gas to kill pathogens. In one embodiment, inert gas is dissolved into a liquid at a pressure greater than ambient pressure. The pressure is later rapidly reduced, which causes inert gas to be released from the liquid. This reduces the number of pathogens in the liquid. Other method steps or processes that do not utilize inert gas are also disclosed.
Patent CA-3109100-A1 (CA)
Inventor: WU DEDONG
IPC: C07F5/02
Filed: 2019-08-21
Abstract: L'invention concerne le (S)-2-amino-N-((3R,5R)-8-hydroxy-6-oxo-7-oxa-1-aza-8-boraspiro[4.7]dodécan-3-yl)-3-méthylbutanamide cristallin sous la forme D et sous la Forme E : Formule (I) ; le (3R,5R)-8-hydroxy-3-((S)-4-isopropyl-2,2-diméthyl-5-oxoimidazolidin-1-yl)-7-oxa-1-aza-8-boraspiro[4.7]dodécan-6-one ou un sel pharmaceutiquement acceptable de celui-ci ou la forme cristalline 1 de celui-ci : Formule (II) ; et des compositions pharmaceutiques et des méthodes d'utilisation associées.
Patent CA-3113018-A1 (CA)
Inventor: EJECKAM FELIX
IPC: G01J3/40
Filed: 2019-09-18
Abstract: Aspects of wireless communication are described, including a radiofrequency (RF) amplifier chip, configured for transmitting or receiving data, comprising a first substrate comprising a first material and a second substrate comprising a second material that is different from the first material. The first substrate and the second substrate may be lattice-matched such that an interface region between the first substrate and the second substrate exhibits an sp3 carbon peak at about 1332 cm1 having a full width half maximum of no more than 5.0 cm1 as measured by Raman spectroscopy. In some aspects, the first substrate and said second substrate permit said chip to transmit or receive data at a transfer rate of at least 500 megabits per second and a frequency of at least 8 GHz. In some aspects, the RF amplifier chip is part of a satellite transmitter.
Patent CA-3113068-A1 (CA)
Title: Stormwater planter system
Inventor: IORIO PAUL ANTHONY
IPC: A01G9/00
Filed: 2019-09-26
Abstract: A stormwater planter system containing plant material being comprised of a container fabricated of concrete, metal, plastic, or the like, that captures surface rainwater runoff or roof rainwater runoff whereby debris, sands, sediment, pollutants within the water are separated, treated and/or attenuated via multiple processes within a predetermined organic and/or non-organic aggregate material layer. The water is then discharged from the container either through internal pipe, or by direct infiltration into the subsurface environment. More particularly, the system incorporates features and structures to enable ease of maintenance, and heathier plant growth without competition from weeds and other non-desirable plant material.
Patent CA-3114080-A1 (CA)
Title: Cogeneration system
Inventor: DEAN ALEXANDER
IPC: F23G7/00
Filed: 2021-04-06
Abstract: A cogeneration system includes, at least, a biomass-burner assembly, a water-heater assembly, a heating-assembly, a compression-tank assembly, and an electricity-generator assembly. Additionally, in some embodiments, the cogeneration further includes a cooling-assembly and a thennoelectric-generator assembly. The cogeneration system burns/combusts a biomass material, preferably wood, to generate wood gas. The wood gas is used to provide heating, cooling and electricity to an area, such as a building or off-the-grid areas such as campgrounds.
Patent CA-3114704-A1 (CA)
Title: Macrocyclic lactone formulations, methods of their preparation and use of the formulations in treating pathologies secondary to ophthalmic parasites
Inventor: VOZONE CARLA
IPC: A61K9/10
Filed: 2019-10-11
Abstract: The invention relates to a method of treating parasitic etiologies of ophthalmic diseases in the eyelash, eyelid, or cutaneous tissue surrounding the eyelash or eyelid by topically applying to the eyelash, eyelid, or cutaneous tissue surrounding the eyelash or eyelid a formulation of antiparasitic agents such as macrocyclic lactone parasiticides, comprising of suspended particles of ivermectin and polymer solid dispersion in a suitable pharmaceutically carrier. The formulation may include particles of ivermectin and a polymer having a D90 particle size below about 10 microns preferably between about 800 nm and about 4 microns. The polymer may be an extended release polymer. The formulation may further include mineral oil and an anhydrous gel. The formulation may have a viscosity between 30,000 cP and about 100,000 cP preferably between about 40,000 cP and about 90,000 cP.
Patent CA-3114741-A1 (CA)
Inventor: KIMURA RYOTA
IPC: H04W92/22
Filed: 2019-09-13
Abstract: This information processing device comprises an acquisition unit (441) for acquiring information pertaining to a second wireless system that performs wireless communication using a radio wave of the frequency band used by a first wireless system, a determination unit (442) for determining a communication parameter of the second wireless system on the basis of the information pertaining to the second wireless system as acquired by the acquisition unit (441), and a notification unit (443) for issuing a notification about the communication parameter determined by the determination unit (442) to other information processing devices.
Patent CA-3115780-A1 (CA)
Title: Tendeur
Inventor: HODJAT YAHYA
IPC: F16H7/12
Filed: 2019-10-10
Abstract: L'invention concerne un tendeur qui comporte une base, un bras de pivot monté pivotant sur la base, un ressort disposé entre le bras de pivot et la base, un élément amortisseur arqué, mis en prise avec une extrémité du ressort, l'élément amortisseur arqué étant mis en prise par frottement avec la base, une poulie tourillonnée au bras de pivot sur un arbre, le bras de pivot comprenant un métal estampé et un bord roulé et une ou plusieurs nervures de renforcement, le ressort et l'arbre étant soudés au laser au bras de pivot.
Patent CA-3116635-A1 (CA)
Inventor: PETKOVICH P MARTIN
IPC: A61K33/26
Filed: 2019-10-25
Abstract: Un procédé de traitement et/ou de prévention de calcification vasculaire peut comprendre l'administration d'un composé métallique mixte à un sujet en ayant besoin.
Patent CA-3121767-A1 (CA)
Inventor: PITTAU SERGE
IPC: B25B11/02
Filed: 2021-06-10
Abstract: Un procédé de fabrication d'un harnais électrique comprenant assemblage d'un fil électrique, d'une gaine de protection, de deux manchons rétractables, d'un organe de référence et d'un organe secondaire, les deux manchons rétractables étant agencés dans un état non retreint, dans une portion de référence du harnais, retreint de référence du manchon rétractable de référence, l'étape de retreint de référence permettant d'immobiliser la gaine de protection par rapport à l'organe de référence, l'organe de référence permettant d'assigner un plan de référence au harnais, dans une portion secondaire du harnais distincte de la portion de référence, positionnement angulaire de l'organe secondaire par rapport au plan de référence selon une orientation angulaire relative, l'orientation angulaire relative étant définie dans un plan perpendiculaire à une direction longitudinale selon laquelle s'étend longitudinalement la gaine de protection, maintien en position de l'organe secondaire dans l'orientation angulaire relative, et retreint secondaire du manchon rétractable secondaire.
Patent CA-3124900-A1 (CA)
Inventor: CADALEN FRANCOIS
IPC: B63C7/20
Filed: 2019-12-20
Abstract: Docking device comprising a docking station capable of being connected to a carrying vessel by means of a cable, the docking station comprising a guide device which comprises a set (E) of arms (51) which are connected to the body and each comprise a distal end (ED) and a proximal end (EP), the set (E) of arms (51) being capable of being in a deployed configuration in which it defines a space flaring towards the rear so as to enable the underwater vehicle to be guided to the stop, the distal end (ED) of each arm (51) being located behind the proximal end (EP) of the arm (51) in the deployed configuration, the set (E) of arms being capable of being in a collapsed configuration in which a distal end (ED) of each arm (51) of the set (E) of arms is closer to the longitudinal axis (x) than in the deployed configuration and in which the distal end (ED) is located in front of the position occupied by the distal end (ED) in the deployed configuration, such that a length, along the axis x, of a space defined by the set (E) of arms (51) behind the stop is smaller in the collapsed configuration than in the deployed configuration.
Patent CA-3125404-A1 (CA)
Inventor: HODAPP TIMOTHY
IPC: E06B3/677
Filed: 2020-01-06
Abstract: Certains modes de réalisation de la présente invention concernent du verre isolé sous vide (VIG) et/ou des procédés de fabrication de celui-ci. Un tube d'épuisement par pompage intégré est formé dans un premier substrat de sorte que, vu en coupe transversale, le premier substrat de verre comprend (a) des première et seconde parties de canal disposées adjacentes à des côtés opposés d'un trou traversant et (b) des première et seconde parties de paroi d'étanchéité délimitées entre celles-ci. Un joint d'étanchéité de bord scelle ensemble les premier et second substrats. Une cavité est délimitée par les premier et second substrats. Des éléments d'espacement disposés entre les premier et second substrats dans la cavité contribuent à maintenir les premier et second substrats dans une relation sensiblement parallèle, espacés l'un par rapport à l'autre. La cavité est évacuée à une pression inférieure à la pression atmosphérique. Les première et seconde parties de paroi d'étanchéité sont de préférence chauffantes pour les amener à s'affaisser ensemble et à former un pont recouvrant le trou traversant, ce qui permet de sceller hermétiquement l'unité VIG.
Patent CA-3130101-A1 (CA)
Title: Electronic submersible pumps for oil and gas applications
Inventor: AZZOUNI SULIMAN M
IPC: E21B33/127
Filed: 2020-02-11
Abstract: A method of removing fluid from a well using a downhole pump includes deploying the downhole pump to a vertical position within a production tubing disposed in the well, securing the downhole pump to the production tubing at the vertical position, powering a motor of the downhole pump with an electrical line of the downhole pump that extends from a surface of the well and that terminates at a profile of the downhole pump, and activating the motor to pump fluid out of the well.